Literature DB >> 17567689

Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production.

Nigel Bourne1, Frank Scholle, Maria Carlan Silva, Shannan L Rossi, Nathan Dewsbury, Barbara Judy, Juliana B De Aguiar, Megan A Leon, D Mark Estes, Rafik Fayzulin, Peter W Mason.   

Abstract

Infection of cells with flaviviruses in vitro is reduced by pretreatment with small amounts of type I interferon (IFN-alpha/beta). Similarly, pretreatment of animals with IFN and experiments using mice defective in IFN signaling have indicated a role for IFN in controlling flavivirus disease in vivo. These data, along with findings that flavivirus-infected cells block IFN signaling, suggest that flavivirus infection can trigger an IFN response. To investigate IFN gene induction by the very first cells infected during in vivo infection with the flavivirus West Nile virus (WNV), we infected mice with high-titer preparations of WNV virus-like particles (VLPs), which initiate viral genome replication in cells but fail to spread. These studies demonstrated a brisk production of IFN in vivo, with peak levels of over 1,000 units/ml detected in sera between 8 and 24 h after inoculation by either the intraperitoneal or footpad route. The IFN response was dependent on genome replication, and WNV genomes and WNV antigen-positive cells were readily detected in the popliteal lymph nodes (pLN) of VLP-inoculated mice. High levels of IFN mRNA transcripts and functional IFN were also produced in VLP-inoculated IFN regulatory factor 3 null (IRF3(-/-)) mice, indicating that IFN production was independent of the IRF3 pathways to IFN gene transcription, consistent with the IFN type produced (predominantly alpha).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567689      PMCID: PMC1951458          DOI: 10.1128/JVI.00316-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment.

Authors:  Frank Scholle; Peter W Mason
Journal:  Virology       Date:  2005-08-18       Impact factor: 3.616

2.  Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Authors:  Joseph M Thompson; Alan C Whitmore; Jennifer L Konopka; Martha L Collier; Erin M B Richmond; Nancy L Davis; Herman F Staats; Robert E Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

Review 3.  Innate immune recognition of viral infection.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2006-02       Impact factor: 25.606

4.  Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression.

Authors:  Meleri Jones; Andrew Davidson; Linda Hibbert; Petra Gruenwald; Joerg Schlaak; Simon Ball; Graham R Foster; Michael Jacobs
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 5.  West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States.

Authors:  Edward B Hayes; Duane J Gubler
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

Review 6.  MasterCARD: a priceless link to innate immunity.

Authors:  John Hiscott; Rongtuan Lin; Peyman Nakhaei; Suzanne Paz
Journal:  Trends Mol Med       Date:  2006-01-06       Impact factor: 11.951

7.  Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.

Authors:  Wen Jun Liu; Xiang Ju Wang; David C Clark; Mario Lobigs; Roy A Hall; Alexander A Khromykh
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Inhibition of interferon signaling by dengue virus.

Authors:  Jorge L Muñoz-Jordan; Gilma G Sánchez-Burgos; Maudry Laurent-Rolle; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

Review 10.  The interferon response circuit: induction and suppression by pathogenic viruses.

Authors:  Otto Haller; Georg Kochs; Friedemann Weber
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

View more
  40 in total

Review 1.  Cell-intrinsic innate immune control of West Nile virus infection.

Authors:  Michael S Diamond; Michael Gale
Journal:  Trends Immunol       Date:  2012-06-20       Impact factor: 16.687

2.  Membrane perturbation elicits an IRF3-dependent, interferon-independent antiviral response.

Authors:  Ryan S Noyce; Kathryne Taylor; Marta Ciechonska; Susan E Collins; Roy Duncan; Karen L Mossman
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses.

Authors:  Evandro R Winkelmann; Douglas G Widman; Jingya Xia; Alison J Johnson; Nico van Rooijen; Peter W Mason; Nigel Bourne; Gregg N Milligan
Journal:  Virology       Date:  2014-01-10       Impact factor: 3.616

4.  Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.

Authors:  Hal P Bogerd; Rebecca L Skalsky; Edward M Kennedy; Yuki Furuse; Adam W Whisnant; Omar Flores; Kimberly L W Schultz; Nicole Putnam; Nicholas J Barrows; Barbara Sherry; Frank Scholle; Mariano A Garcia-Blanco; Diane E Griffin; Bryan R Cullen
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

6.  A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.

Authors:  Elizabeth A Caine; Louise H Moncla; Monica D Ronderos; Thomas C Friedrich; Jorge E Osorio
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

7.  Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes.

Authors:  Charles E McGee; Alexandr V Shustov; Konstantin Tsetsarkin; Ilya V Frolov; Peter W Mason; Dana L Vanlandingham; Stephen Higgs
Journal:  Vector Borne Zoonotic Dis       Date:  2010-04       Impact factor: 2.133

8.  Mouse gammaherpesvirus-68 infection acts as a rheostat to set the level of type I interferon signaling in primary macrophages.

Authors:  Brittani M Wood; Wadzanai P Mboko; Bryan C Mounce; Vera L Tarakanova
Journal:  Virology       Date:  2013-05-23       Impact factor: 3.616

9.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

10.  Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.

Authors:  Stephane Daffis; Mehul S Suthar; Kristy J Szretter; Michael Gale; Michael S Diamond
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.